Home › NDC Lookup › RxCUI directory › RxCUI 351427

24 HR nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] — RxCUI 351427

RxNorm drug concept · Semantic branded drug
RxCUI 351427 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351427
Official name24 HR nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNicoderm C-Q 0.583 MG/HR 24HR Transdermal Patch; NICODERM CQ (Step 2) 14 MG/Day 24HR Transdermal System; 24 HR Nicoderm C-Q 0.583 MG/HR Transdermal System; Nicoderm CQ (Step 2) 14 MG/Day 24HR Transdermal Patch
FDA products mapped3
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nicotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It eases withdrawal symptoms, including cravings, while you quit smoking. You need to stop smoking completely when you start it. Finishing the full step-down program improves your...
  • Use dry, clean, hairless skin. Peel off the backing, press the patch on and hold it for 10 seconds. Change it at the same time each day, use a new spot, and wash your hands afterwa...
  • Vivid dreams and sleep trouble can happen. You can take the patch off at bedtime and put a new one on in the morning. If you crave cigarettes as soon as you wake up, wear it for th...
  • I'm having strange dreams or trouble sleeping. What should I do?
📖 Read our full Nicotine Transdermal Patch guide →

🕸️ Concept Web — How 24 HR nicotine 0.583 MG/HR Transdermal System [N... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR nicotine 0.583 MG/HR Transdermal System [Nicoderm C-Q] RxCUI 351427

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nicotine 7407
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nicoderm C-Q 352799
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nicotine Transdermal System 1805957
    • Nicotine Topical Product 1158682
    • Nicotine Transdermal Product 1295678
    • Nicotine Transdermal System [Nicoderm C-Q] 1806000
    • Nicoderm C-Q Topical Product 1183366
    • Nicoderm C-Q Transdermal Product 1296791
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Nicotine 0.583 MG/HR [Nicoderm C-Q] SBDC · 685563
  • Nicotine Transdermal System [Nicoderm C-Q] SBDF · 1806000
  • Nicoderm C-Q Topical Product SBDG · 1183366
  • Nicoderm C-Q Transdermal Product SBDG · 1296791
  • Nicoderm C-Q BN · 352799

📦 FDA Products & Package NDCs

3 products · 9 package NDCs
9 package NDCs map to RxCUI 351427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00135-0194-01 7 PATCH in 1 CARTON (0135-0194-01) / 24 h in 1 PATCH NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0194-02 14 PATCH in 1 CARTON (0135-0194-02) / 24 h in 1 PATCH NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0194-03 1 CARTON in 1 PACKAGE (0135-0194-03) / 21 PATCH in 1 CARTON... NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0194-05 14 PATCH in 1 CARTON (0135-0194-05) / 24 h in 1 PATCH (0135... NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0195-02 14 PATCH in 1 CARTON (0135-0195-02) / 24 h in 1 PATCH NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0195-03 1 CARTON in 1 PACKAGE (0135-0195-03) / 21 PATCH in 1 CARTON... NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0195-05 14 PATCH in 1 CARTON (0135-0195-05) / 24 h in 1 PATCH (0135... NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0196-02 14 PATCH in 1 CARTON (0135-0196-02) / 24 h in 1 PATCH NICODERM CQ Haleon US Holdings LLC 2011-05-12
00135-0196-05 14 PATCH in 1 CARTON (0135-0196-05) / 24 h in 1 PATCH (0135... NICODERM CQ Haleon US Holdings LLC 2011-05-12
Observed labelers: Haleon US Holdings LLC (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.